{{Rsnum
|rsid=7159888
|Chromosome=14
|position=65291924
|Orientation=plus
|GMAF=0.4008
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 52.2 | 32.7
| HCB | 51.8 | 40.9 | 7.3
| JPT | 63.7 | 31.9 | 4.4
| YRI | 53.1 | 38.1 | 8.8
| ASW | 47.4 | 45.6 | 7.0
| CHB | 51.8 | 40.9 | 7.3
| CHD | 56.9 | 35.8 | 7.3
| GIH | 32.7 | 54.5 | 12.9
| LWK | 50.0 | 44.5 | 5.5
| MEX | 32.8 | 44.8 | 22.4
| MKK | 55.1 | 37.2 | 7.7
| TSI | 28.4 | 45.1 | 26.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21203500
|Trait=None
|Title=Genomics Meets Glycomics-The First GWAS Study of Human N-Glycome Identifies HNF1± as a Master Regulator of Plasma Protein Fucosylation
|RiskAllele=A
|Pval=3E-18
|OR=0.2600
|ORtxt=[0.20-0.32] unit increase
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=G
  |Pval=2E-6
  |OR=.15
  |ORtxt=[0.086-0.207] unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}